Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
nfzAuLRnRn7AGJTQ
Listen
